Catalyst Wire Dossier Catalyst Wire Dossier

Difamilast Ointment 1%

Difamilast · Acrotech Biopharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Difamilast Ointment 1%, covering 2024-08-09 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis [Phase 3]

See pricing